Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06066424 · ClinicalTrials.gov registry record · Phase 1

Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)

A Phase 1 study of Solid Tumors, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
Phase 1
Development phase
54
Enrollment target
1
Study location

NCT06066424 is a Phase 1 study of Solid Tumors that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 54 participants, below the 284-participant average among 125 other Solid Tumors trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06066424, a Phase 1 study of Solid Tumors, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
Phase 1
Development phase
54 participants
Enrollment target
1
Study location

Study Summary

To find the recommended dose of TROP2- CAR-NK cells that can be given to participants with advanced forms of solid tumors.

Conditions Studied

Solid Tumors

Interventions

  • DRUG Cyclophosphamide
  • DRUG Fludarabine phosphate
  • DRUG Rimiducid
  • DRUG TROP2-CAR-NK Cells

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2023-10-24
Est. Completion 2040-04-30
Phase Phase 1

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06066424

The ClinicalTrials.gov registry entry for NCT06066424 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 284-participant average among 125 other Solid Tumors trials with a reported enrollment target (81% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Solid Tumors appearing as the primary indexed condition, and to 4 interventions - of which Cyclophosphamide is the first listed.

NCT06066424 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06066424 about?

NCT06066424 is a clinical study titled "Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)". To find the recommended dose of TROP2- CAR-NK cells that can be given to participants with advanced forms of solid tumors.

What is the current status of trial NCT06066424?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 54 participants. The study started on 2023-10-24. Estimated completion is 2040-04-30.

What conditions does trial NCT06066424 study?

This clinical trial studies the following conditions: Solid Tumors.

What interventions are being tested in trial NCT06066424?

The interventions under investigation include: Cyclophosphamide (DRUG), Fludarabine phosphate (DRUG), Rimiducid (DRUG), TROP2-CAR-NK Cells (DRUG).

Who is sponsoring clinical trial NCT06066424?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06066424 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Solid Tumors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Solid Tumors

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.